Cargando…
Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses wit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244831/ https://www.ncbi.nlm.nih.gov/pubmed/32463872 http://dx.doi.org/10.1093/ejcts/ezaa139 |
_version_ | 1783716001445052416 |
---|---|
author | Asou, Toshihide Kawataki, Motoyoshi Takeda, Yuko Asai, Hidetsugu Tachibana, Tsuyoshi Toyoshima, Katsuaki Kim, Ki-Sung Ueda, Hideaki |
author_facet | Asou, Toshihide Kawataki, Motoyoshi Takeda, Yuko Asai, Hidetsugu Tachibana, Tsuyoshi Toyoshima, Katsuaki Kim, Ki-Sung Ueda, Hideaki |
author_sort | Asou, Toshihide |
collection | PubMed |
description | OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses with Ebstein anomaly were analysed in this study and divided into 2 groups. The control group comprised 25 foetuses, referred to us before 2008, and the study group was composed of 27 foetuses, referred to us after 2009. The right atrial area index was defined as high risk when it was >1.5. We applied our management approach to 6 high-risk neonates in the study group. This approach consisted of reducing the size of the right side of the heart through a 2-stage process: (i) right atrial plication without the use of a bypass and (ii) a Starnes procedure. Cox proportional hazards models were used to evaluate the effects of our management approach on the survival rates of the neonates. RESULTS: The mean follow-up period was 7.5 ± 3.3 years. All 6 high-risk neonates in the study group survived. The overall hazard ratio was 0.12 (95% confidence interval of 0.03–0.43) in the study group as compared with the control group (P = 0.0007). A Fontan operation was completed in all but 1 case, with the remaining case awaiting a Fontan operation. CONCLUSIONS: We suggest that a rapid 2-stage Starnes approach can be effective in the treatment of high-risk neonates with Ebstein anomaly. |
format | Online Article Text |
id | pubmed-8244831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-82448312021-07-01 Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly Asou, Toshihide Kawataki, Motoyoshi Takeda, Yuko Asai, Hidetsugu Tachibana, Tsuyoshi Toyoshima, Katsuaki Kim, Ki-Sung Ueda, Hideaki Eur J Cardiothorac Surg Congenital OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses with Ebstein anomaly were analysed in this study and divided into 2 groups. The control group comprised 25 foetuses, referred to us before 2008, and the study group was composed of 27 foetuses, referred to us after 2009. The right atrial area index was defined as high risk when it was >1.5. We applied our management approach to 6 high-risk neonates in the study group. This approach consisted of reducing the size of the right side of the heart through a 2-stage process: (i) right atrial plication without the use of a bypass and (ii) a Starnes procedure. Cox proportional hazards models were used to evaluate the effects of our management approach on the survival rates of the neonates. RESULTS: The mean follow-up period was 7.5 ± 3.3 years. All 6 high-risk neonates in the study group survived. The overall hazard ratio was 0.12 (95% confidence interval of 0.03–0.43) in the study group as compared with the control group (P = 0.0007). A Fontan operation was completed in all but 1 case, with the remaining case awaiting a Fontan operation. CONCLUSIONS: We suggest that a rapid 2-stage Starnes approach can be effective in the treatment of high-risk neonates with Ebstein anomaly. Oxford University Press 2020-05-27 /pmc/articles/PMC8244831/ /pubmed/32463872 http://dx.doi.org/10.1093/ejcts/ezaa139 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Congenital Asou, Toshihide Kawataki, Motoyoshi Takeda, Yuko Asai, Hidetsugu Tachibana, Tsuyoshi Toyoshima, Katsuaki Kim, Ki-Sung Ueda, Hideaki Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title | Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title_full | Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title_fullStr | Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title_full_unstemmed | Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title_short | Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly |
title_sort | rapid two-stage starnes approach in high-risk neonates with ebstein anomaly |
topic | Congenital |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244831/ https://www.ncbi.nlm.nih.gov/pubmed/32463872 http://dx.doi.org/10.1093/ejcts/ezaa139 |
work_keys_str_mv | AT asoutoshihide rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT kawatakimotoyoshi rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT takedayuko rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT asaihidetsugu rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT tachibanatsuyoshi rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT toyoshimakatsuaki rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT kimkisung rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly AT uedahideaki rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly |